Avid Bioservices Inc (CDMO)

[Protector]

Wernaaa, yes it is.

Actually the Microsoft of Biotech will be in what Bavituximab will do just like for Microsoft it was what the DOS Operating System did in an emerging market of personal computers.

And again, SUNRISE with its abnormally and dramatically outperforming control arm does not change anything to that given it was communicated that Bavituximab itself performed as expected in the clinical trial design.

I think we will at least agree that such expectation of performance is one that improves on the SOC and that the CTRL arm has at least an expectation to do as good as the SOC.

That the CTRL arm then suddenly does dramatically better then the expectations of the SOC (and actually as the performance of the SOC over the last TWO DECADES ... yes) is the anomaly.

That the FDA regulation says you need to beat your OWN control arm not taking into account any under-performance or out-performance is the LOTTERY part of a clinical trial. Shame on the FDA and all that keep them in place because MANY people will die earlier then they should because of this little 'cheat-grade' rule.

So yes, the Microsoft of Biotechnology is still on or I would be here any more.